Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial

✍ Scribed by Dutton, Susan J; Ferry, David R; Blazeby, Jane M; Abbas, Haider; Dahle-Smith, Asa; Mansoor, Wasat; Thompson, Joyce; Harrison, Mark; Chatterjee, Anirban; Falk, Stephen; Garcia-Alonso, Angel; Fyfe, David W; Hubner, Richard A; Gamble, Tina; Peachey, Lynnda; Davoudianfar, Mina; Pearson, Sarah R; Julier, Patrick; Jankowski, Janusz; Kerr, Rachel; Petty, Russell D

• Book ID: 125796201
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 958 KB
• Volume: 15
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(14)70024-5